Package 0078-0937-91

{"route": ["ORAL"], "spl_id": "59dff6dc-c0b0-4f26-9738-32f8a6540033", "openfda": {"nui": ["N0000175481", "M0001301", "N0000182140", "N0000182138", "N0000193937", "N0000182139", "N0000187062", "N0000185504", "N0000182137", "N0000190114"], "unii": ["4784C8E03O"], "rxcui": ["2118606", "2118612"], "spl_set_id": ["5552884e-10ea-450c-9658-d3d4f33c946e"], "pharm_class_cs": ["Anthelmintics [CS]"], "pharm_class_epc": ["Anthelmintic [EPC]"], "pharm_class_moa": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2A6 Inhibitors [MoA]", "Cytochrome P450 2B6 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 TABLET in 1 BLISTER PACK (0078-0937-91)", "package_ndc": "0078-0937-91", "marketing_start_date": "20190213"}], "brand_name": "EGATEN", "product_id": "0078-0937_59dff6dc-c0b0-4f26-9738-32f8a6540033", "dosage_form": "TABLET", "pharm_class": ["Anthelmintic [EPC]", "Anthelmintics [CS]", "Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2A6 Inhibitors [MoA]", "Cytochrome P450 2B6 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]"], "product_ndc": "0078-0937", "generic_name": "triclabendazole", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EGATEN", "active_ingredients": [{"name": "TRICLABENDAZOLE", "strength": "250 mg/1"}], "application_number": "NDA208711", "marketing_category": "NDA", "marketing_start_date": "20190213", "listing_expiration_date": "20261231"}